Immunocore Holdings (Immunocore Holdings) Total Assets : $1,263.0 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Immunocore Holdings Total Assets?

Immunocore Holdings's Total Assets for the quarter that ended in Mar. 2024 was $1,263.0 Mil.

During the past 12 months, Immunocore Holdings's average Total Assets Growth Rate was 78.60% per year. During the past 3 years, the average Total Assets Growth Rate was 34.00% per year. During the past 5 years, the average Total Assets Growth Rate was 13.10% per year.

During the past 6 years, Immunocore Holdings's highest 3-Year average Total Assets Growth Rate was 34.00%. The lowest was -1.80%. And the median was 2.80%.

Total Assets is connected with ROA %. Immunocore Holdings's annualized ROA % for the quarter that ended in Mar. 2024 was -12.30%. Total Assets is also linked to Revenue through Asset Turnover. Immunocore Holdings's Asset Turnover for the quarter that ended in Mar. 2024 was 0.09.

Immunocore Holdings Total Assets Historical Data

The historical data trend for Immunocore Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunocore Holdings Total Assets Chart

Immunocore Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

243.32

265.05

401.29

641.61

755.70

Immunocore Holdings Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															522.49	556.01	574.41	755.70	1,263.01

Immunocore Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Immunocore Holdings's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	466.89	+	288.808
	=	755.7

Immunocore Holdings's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	456.841	+	806.166
	=	1,263.0

Immunocore Holdings (NAS:IMCR) Total Assets Explanation

Total Assets is connected with ROA %.

Immunocore Holdings's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-124.2	/	( (755.697	+	1263.008)	/ 2 )
	=	-124.2	/	1009.3525
	=	-12.30 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Immunocore Holdings's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	89.583	/	( (755.697	+	1263.008)	/ 2 )
=	89.583	/	1009.3525
=	0.09

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Immunocore Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of Immunocore Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunocore Holdings (Immunocore Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (NAS:IMCR) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

6YG:Germany 6YG:Germany

Address

92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY

Website

https://www.immunocore.com

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.